Category: Jurisdictions
-
Doctrine of equivalents removes painkiller from German market: GrĂźnenthal wins preliminary injunction on appeal
A pharma patent and unfair competition dispute has taken a remarkable turn as the Dusseldorf Higher Regional Court granted a preliminary injunction based on infringement by equivalents.
-
Samsung, Headwater settle wireless patent dispute
Samsung and Headwater Research have settled a two-year patent infringement dispute.
-
Regeneron makes strides in global Eylea patent enforcement campaign: settles with Sandoz, files fresh UK suits
Regeneron has settled its year-long patent infringement dispute with Sandoz over several patents related to its eye disease drug Eylea, and filed a fresh lawsuit against two more rivals over the same drug in the High Court of Justice for England & Wales.
-
Pharma and Biotech Patent Litigation Summit Europe returns in 2026: rebranded event features tech industry track, UPC litigation forum
Kisaco Researchâs annual Pharma and Biotech Patent Litigation Summit Europe will take place from January 19 to January 21 in the Beurs van Berlage, Amsterdam, with ip fray as an official media partner.
-
InterDigital’s Brazilian double whammy against Disney: preliminary (but merits-based) injunction over two streaming patents
InterDigital’s merits-based two-patent injunction is harder to get stayed or overturned than most Brazilian patent PIs.
-
Nokia appeals UK order to disclose SEP contracts to Acer, ASUS, Hisense lawyers, raising procedural issues
Nokia is asking the England & Wales Court of Appeal for an emergency stay of a disclosure order by Mr Justice Mellor. Nokia raises fundamental procedural issues.
-
Xiaomi seeks UK FRAND ruling in ASUS, Innovative Sonic SEP dispute
Xiaomi has filed a FRAND suit against ASUSTeK and its affiliate Innovative Sonic in the High Court of Justice for England & Wales, in response to suits they filed against it in the UPC and Germany.
-
Pfizer, BioNTech hit back against GSK mRNA suits in UPC, Ireland: file UK revocation actionÂ
The move does not come as a major surprise, given the pharma companiesâ previous success against GlaxoSmithKline in the UK.
-
TP-Link’s UK lawsuit against Huawei appears uneconomical: widely accepted pool option and potential German blowback
TP-Link filed a UK lawsuit against Huawei, but the terms of the Sisvel WiFi 6 pool through which those patents are available have been widely accepted and German courts won’t let UK courts torpedo their cases.
-
Acer seeking counterleverage against Nokia through “threat letters” in U.S. despite highly asymmetric SEP portfolios and sales volumes: DJ action
Acer sent “threat letters” to U.S. telecommunications carriers using Nokia equipment, provoking a declaratory judgment complaint.